BGLAP and osteonecrosis: Eight weeks after the induction of osteonecrosis, Alendronate combined with the DFO group demonstrated higher expression of osteocalcin and VEGF and upregulated signal factors of HIF-1α and β-catenin, and decreased level of RANKL.